DK1331972T3 - Farmaceutiske præparater - Google Patents

Farmaceutiske præparater

Info

Publication number
DK1331972T3
DK1331972T3 DK01982270T DK01982270T DK1331972T3 DK 1331972 T3 DK1331972 T3 DK 1331972T3 DK 01982270 T DK01982270 T DK 01982270T DK 01982270 T DK01982270 T DK 01982270T DK 1331972 T3 DK1331972 T3 DK 1331972T3
Authority
DK
Denmark
Prior art keywords
pharmaceuticals
Prior art date
Application number
DK01982270T
Other languages
Danish (da)
English (en)
Inventor
Simon David Bateman
Alberto Gimona
Jurij Holinej
Jasper Huels
Sumedha Jayawardene
Maha Y Khaled
Anees Abdulquadar Karnachi
Lochlainn Eimear Mairin Nic
Richard Macerata
Victor Sloan
Argeris Jerry Karabelas
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK1331972T3 publication Critical patent/DK1331972T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK01982270T 2000-09-11 2001-09-10 Farmaceutiske præparater DK1331972T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23165500P 2000-09-11 2000-09-11
US23226100P 2000-09-14 2000-09-14
PCT/EP2001/010448 WO2002020090A2 (en) 2000-09-11 2001-09-10 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
DK1331972T3 true DK1331972T3 (da) 2007-11-05

Family

ID=26925315

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01982270T DK1331972T3 (da) 2000-09-11 2001-09-10 Farmaceutiske præparater

Country Status (28)

Country Link
US (2) US20020061932A1 (enExample)
EP (1) EP1331972B1 (enExample)
JP (2) JP2004527458A (enExample)
KR (1) KR20030036730A (enExample)
CN (1) CN100490797C (enExample)
AR (1) AR030630A1 (enExample)
AT (1) ATE366128T1 (enExample)
AU (2) AU2002213900C1 (enExample)
BR (1) BR0113809A (enExample)
CA (1) CA2416771C (enExample)
CY (1) CY1107729T1 (enExample)
CZ (1) CZ2003673A3 (enExample)
DE (1) DE60129238T2 (enExample)
DK (1) DK1331972T3 (enExample)
ES (1) ES2290181T3 (enExample)
HU (1) HUP0301128A3 (enExample)
IL (2) IL154238A0 (enExample)
MX (1) MXPA03002105A (enExample)
MY (1) MY126117A (enExample)
NO (1) NO20031095D0 (enExample)
NZ (1) NZ524785A (enExample)
PE (1) PE20020351A1 (enExample)
PL (1) PL359721A1 (enExample)
PT (1) PT1331972E (enExample)
RU (1) RU2316324C2 (enExample)
SI (1) SI1331972T1 (enExample)
SK (1) SK2902003A3 (enExample)
WO (1) WO2002020090A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR036312A1 (es) * 2001-08-31 2004-08-25 Novartis Ag Composicion farmaceutica
GB0201520D0 (en) * 2002-01-23 2002-03-13 Novartis Ag Pharmaceutical uses
CA2476744A1 (en) * 2002-03-07 2003-09-12 Novartis Ag Solid pharmaceutical compositions comprising lumiracoxib
US7220749B2 (en) 2002-06-11 2007-05-22 Nitromed, Inc. Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
AR042206A1 (es) 2002-11-26 2005-06-15 Novartis Ag Acidos fenilaceticos y derivados
TWI327913B (en) * 2003-03-12 2010-08-01 Novartis Ag Pharmaceutical composition comprising 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid
US20050131028A1 (en) * 2003-09-11 2005-06-16 Pharmacia Corporation Methods and compositions for the extended duration treatment of pain, inflammation and inflammation-related disorders
RU2423979C2 (ru) * 2005-06-17 2011-07-20 АФТ Фармасьютикалз Лимитед Новая фармацевтическая композиция и ее применение в способе лечения пациентов с гиперемией и отеком слизистой оболочки верхних дыхательных путей
FR2898492B1 (fr) * 2006-03-15 2008-06-06 Pierre Fabre Medicament Sa Comprimes orodispersibles de domperidone
US20080014228A1 (en) * 2006-07-14 2008-01-17 Olivia Darmuzey Solid form
WO2008086537A2 (en) * 2007-01-11 2008-07-17 Analog Devices, Inc. Aluminum based bonding of semiconductor wafers
AU2009282901A1 (en) * 2008-08-22 2010-02-25 Novartis Ag Use of a COX-2 inhibitor for the treatment of a COX-2 dependent disorder in a patient not carrying HLA alleles associated with hepatotoxicity
US8227451B2 (en) 2008-11-12 2012-07-24 Auspex Pharmaceuticals Phenylacetic acid inhibitors of cyclooxygenase
CN103773596B (zh) * 2013-12-31 2016-05-18 上海复力生物医药科技有限公司 磷虾油的制备方法
KR102557900B1 (ko) 2016-09-07 2023-07-19 트러스티즈 오브 터프츠 칼리지 면역-dash 억제제와 pge2 길항제를 이용한 병행 요법
EP3687505A1 (en) 2017-09-26 2020-08-05 Tesaro Inc. Niraparib formulations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0701449T3 (da) * 1993-06-08 2003-11-10 Novartis Ag Fremgangsmåde til fremstilling af en oral fast dosisform indeholdende diclofenac
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
EP0910368A1 (en) * 1996-05-17 1999-04-28 Merck & Co., Inc. Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
CO4960662A1 (es) * 1997-08-28 2000-09-25 Novartis Ag Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados
SA99191255B1 (ar) * 1998-11-30 2006-11-25 جي دي سيرل اند كو مركبات سيليكوكسيب celecoxib
AR036312A1 (es) * 2001-08-31 2004-08-25 Novartis Ag Composicion farmaceutica

Also Published As

Publication number Publication date
SI1331972T1 (sl) 2007-12-31
CA2416771A1 (en) 2002-03-14
WO2002020090A9 (en) 2003-10-30
WO2002020090A3 (en) 2003-05-30
CY1107729T1 (el) 2013-04-18
CZ2003673A3 (cs) 2003-06-18
HUP0301128A3 (en) 2005-04-28
AU2002213900B2 (en) 2006-02-16
US20040186179A1 (en) 2004-09-23
PT1331972E (pt) 2007-10-16
CN1455691A (zh) 2003-11-12
CA2416771C (en) 2010-11-02
MXPA03002105A (es) 2003-06-19
US20020061932A1 (en) 2002-05-23
AR030630A1 (es) 2003-08-27
AU2002213900C1 (en) 2006-07-27
EP1331972B1 (en) 2007-07-04
DE60129238T2 (de) 2008-03-06
MY126117A (en) 2006-09-29
CN100490797C (zh) 2009-05-27
IL154238A (en) 2008-11-26
WO2002020090A2 (en) 2002-03-14
JP2011144194A (ja) 2011-07-28
DE60129238D1 (de) 2007-08-16
RU2316324C2 (ru) 2008-02-10
JP2004527458A (ja) 2004-09-09
NZ524785A (en) 2005-10-28
ES2290181T3 (es) 2008-02-16
AU1390002A (en) 2002-03-22
IL154238A0 (en) 2003-09-17
EP1331972A2 (en) 2003-08-06
HUP0301128A2 (hu) 2003-10-28
KR20030036730A (ko) 2003-05-09
PE20020351A1 (es) 2002-06-14
PL359721A1 (en) 2004-09-06
NO20031095L (no) 2003-03-10
SK2902003A3 (en) 2003-10-07
NO20031095D0 (no) 2003-03-10
BR0113809A (pt) 2003-07-29
ATE366128T1 (de) 2007-07-15

Similar Documents

Publication Publication Date Title
NO20003968D0 (no) Farmasøytiske preparater
ATE290000T1 (de) Muscarinagonisten
DE10136334B8 (de) Hochgeschwindigkeitsvertikalresonatoroberflächenemissionslaser
ATE312098T1 (de) Thiazinoxazolidinon
ATA2932001A (de) Schneefräse
DE50102988D1 (de) Bodenwischer
DE50100710D1 (de) Wischblatt
ATE262530T1 (de) Indolochinazolinone
NO20030276L (no) Fremgangsmåte
ATE298751T1 (de) 7-oxopyridoryrimidine
DK1331972T3 (da) Farmaceutiske præparater
AR028336A1 (es) 4-hidroxi-tetrahidropiridonas fenilsubstituidas
DE10196064T1 (de) Halbleiterfotodektionsgerät
DE50100817D1 (de) Kugelgelenk
DE50011511D1 (de) Blowby-Heizung
AR028061A1 (es) 2-enamino-cetonitrilos fenil-substituidos
AR027931A1 (es) Antitranspirantes
ATE476423T1 (de) Benzoylpyridazine
DE10052925B4 (de) Schaukelbett
DE50007634D1 (de) Kardioplegieballonkatheter
DE10085445T1 (de) Drahterodierbearbeitungseinrichtung
DE10195909T1 (de) Viehfüttervorrichtung
AR027982A1 (es) Aril- y heteroarilsulfonatos
ATE284887T1 (de) Thienopyrrolidinone
DE50010192D1 (de) Intaglio-druckmaschine